{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:42Z","timestamp":1790185242235,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.amjcard.2016.02.049","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T02:33:12Z","timestamp":1456885992000},"page":"1691-1696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease"],"prefix":"10.1016","volume":"117","author":[{"given":"Isabel S.","family":"Bazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-8103","authenticated-orcid":false,"given":"Wassim H.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.02.049_bib1","first-page":"1","article-title":"Prevalence of Obesity Among Adults and Youth: United States, 2011-2014","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.amjcard.2016.02.049_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society Clinical Practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2016.02.049_bib3","series-title":"FDA Announces Withdrawal Fenfluramine and Dexfenfluramine (Fen-phen)","year":"1997"},{"key":"10.1016\/j.amjcard.2016.02.049_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.02.049_bib5","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/pds.2044","article-title":"Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus","volume":"19","author":"Weill","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjcard.2016.02.049_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.02.049_bib7","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.02.049_bib8","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1378\/chest.121.3_suppl.97S","article-title":"Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension","volume":"121","author":"Eddahibi","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2016.02.049_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00008211","article-title":"REVEAL: a contemporary US pulmonary arterial hypertension registry","volume":"21","author":"McGoon","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.amjcard.2016.02.049_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCULATIONAHA.110.963983","article-title":"Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases","volume":"122","author":"McLaughlin","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.02.049_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pharmthera.2013.02.002","article-title":"Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension","volume":"138","author":"Thomas","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2016.02.049_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-60761-500-2_20","article-title":"The serotonin hypothesis of pulmonary hypertension revisited","volume":"661","author":"Maclean","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.amjcard.2016.02.049_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/17512433.1.6.749","article-title":"Role of the serotonin transporter in pulmonary arterial hypertension","volume":"1","author":"Dempsie","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2016.02.049_bib14","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.metabol.2013.08.012","article-title":"Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature","volume":"62","author":"Zhang","year":"2013","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.amjcard.2016.02.049_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International primary pulmonary hypertension study group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.02.049_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.117.3.870","article-title":"Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension","volume":"117","author":"Rich","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2016.02.049_bib17","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjcard.2016.02.049_bib18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.02.049_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjp.2008.241","article-title":"Pulmonary hypertension: therapeutic targets within the serotonin system","volume":"155","author":"Dempsie","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.amjcard.2016.02.049_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","article-title":"Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension","volume":"100","author":"Rothman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.02.049_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09059180.00003313","article-title":"Drug-induced pulmonary arterial hypertension: a recent outbreak","volume":"22","author":"Montani","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.amjcard.2016.02.049_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.amjcard.2016.02.049_bib23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1183\/09031936.00188611","article-title":"Pulmonary hypertension associated with benfluorex exposure","volume":"40","author":"Savale","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2016.02.049_bib24","series-title":"Food and Drug Administration: Warning on Hydroxycut Products","year":"2009"},{"key":"10.1016\/j.amjcard.2016.02.049_bib25","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","article-title":"Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids","volume":"343","author":"Haller","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.02.049_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"Smith","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.02.049_bib27","doi-asserted-by":"crossref","first-page":"e000173","DOI":"10.1136\/openhrt-2014-000173","article-title":"Lorcaserin for the treatment of obesity? A closer look at its side effects","volume":"1","author":"DiNicolantonio","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2016.02.049_bib28","unstructured":"Food and drug administration: lorcaserin medical review. Cent Drug Eval Res\u00a02012."},{"key":"10.1016\/j.amjcard.2016.02.049_bib29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.130.6.1657","article-title":"Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?","volume":"130","author":"Chin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2016.02.049_bib30","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.cjca.2014.09.031","article-title":"The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension","volume":"30","author":"Fox","year":"2014","journal-title":"Can J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916303095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916303095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:56:52Z","timestamp":1748779012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916303095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0002914916303095"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.02.049","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726356503.793519973","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}